Stivarga is the standard third-line treatment for metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma
This is the first drug to receive a recommendation for this preventative indication in the European Union
With US$ 30.46 billion in exports and robust manufacturing capabilities, the industry is poised to expand into high-value drugs while strengthening ESG and compliance standards
EBITDA was Rs. 2,359.6 crore in the quarter ended September 30, 2025
The new shadow roll-on delivers strong on-shelf presence with its modern rounded-base design
The trial will evaluate safety endpoints including dose-limiting toxicities and adverse events
OncoMate MSI Dx Analysis System is a PCR-based assay designed to evaluate MSI status in tumor tissue
FIBROSARC did not meet its primary PFS endpoint in the final analysi
Enabling a new era in minimally invasive obesity treatment across Europe
The approval granted with zero supplementation requests is an important milestone in Glenmark’s respiratory pipeline
Subscribe To Our Newsletter & Stay Updated
